Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039537 | SCV000063226 | benign | not specified | 2015-06-08 | criteria provided, single submitter | clinical testing | Phe5262Phe in Exon 74 of GPR98: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.5% (47/9728) of Af rican chromosomes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs369083434). |
Eurofins Ntd Llc |
RCV000725984 | SCV000341009 | uncertain significance | not provided | 2016-05-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000725984 | SCV001725221 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725984 | SCV001818813 | likely benign | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004549460 | SCV004783962 | likely benign | ADGRV1-related disorder | 2019-10-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |